Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Composition of Chinese traditional medicine for treating cardiovascular disease and cerebrovascular disease

A technology for cardiovascular and cerebrovascular diseases and traditional Chinese medicine preparations, which can be applied to cardiovascular system diseases, drug combinations, drug delivery, etc., and can solve problems such as expensive ingredients, palliatives rather than root causes, and inaccurate curative effects

Active Publication Date: 2007-10-10
YABAO PHARMA GRP CO LTD
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0020] In recent years, with the deepening of clinical research, many traditional Chinese medicine preparations for the treatment of cardiovascular and cerebrovascular diseases have appeared on the market. while interrupting the use of

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0076] Prescription: Astragalus 10 kg, safflower 10 kg, 1000 freeze-dried injections were prepared.

[0077] Preparation method:

[0078] Preparation of Astragalus extract: Astragalus decoction pieces were soaked in 8 times the amount of deionized water for 1 hour, heated and decocted for extraction for 3 hours, filtered, and the filtrate was used for later use; After 2 hours, filter. Combine the filtrates three times, concentrate under reduced pressure to a relative density of 1.10-1.15 (50°C), cool to room temperature, add 95% ethanol until the alcohol content reaches 60%, and refrigerate for 12 hours. The supernatant was poured out, and the dregs were centrifugally filtered. Combine the supernatant and filtrate, recover ethanol under reduced pressure and concentrate to a relative density of 1.10-1.15 (50°C). Dilute the concentrated solution with 0.5 times the amount of water and inject it into D 101 In the macroporous resin column, first elute with deionized water, then...

Embodiment 2

[0082] Prescription: Astragalus 10 kg, safflower 10 kg, prepared solution injection 1000, each 2ml.

[0083] Preparation method:

[0084] Preparation of Astragalus extract: Astragalus decoction pieces were soaked in 8 times the amount of deionized water for 1 hour, heated and decocted for extraction for 3 hours, filtered, and the filtrate was used for later use; After 2 hours, filter. Combine the filtrates three times, concentrate under reduced pressure to a relative density of 1.10-1.15 (50°C), cool to room temperature, add 95% ethanol until the alcohol content reaches 60%, and refrigerate for 12 hours. The supernatant was poured out, and the dregs were centrifugally filtered. Combine the supernatant and filtrate, recover ethanol under reduced pressure and concentrate to a relative density of 1.10-1.15 (50°C). Dilute the concentrated solution with 0.5 times the amount of water and inject it into D 101 In the macroporous resin column, first elute with deionized water, then...

Embodiment 3

[0088] Prescription: Astragalus 1 kg, safflower 10 kg, 1000 sticks of freeze-dried powder for injection.

[0089] Preparation method:

[0090] Preparation of Astragalus extract: Astragalus decoction pieces were soaked in 8 times the amount of deionized water for 1 hour, heated and decocted for extraction for 3 hours, filtered, and the filtrate was used for later use; After 2 hours, filter. Combine the filtrates three times, concentrate under reduced pressure to a relative density of 1.10-1.15 (50°C), cool to room temperature, add 95% ethanol until the alcohol content reaches 60%, and refrigerate for 12 hours. The supernatant was poured out, and the dregs were centrifugally filtered. Combine the supernatant and filtrate, recover ethanol under reduced pressure and concentrate to a relative density of 1.10-1.15 (50°C). Dilute the concentrated solution with 0.5 times the amount of water and inject it into D 101 In the macroporous resin column, first elute with deionized water,...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A Chinese medicine for treating the cardiovascular and cerebrovascular diseases is prepared from astragalus root and safflower in weight ratio of 1:1.

Description

Technical field: [0001] The invention relates to a traditional Chinese medicine preparation for treating cardiovascular and cerebrovascular diseases, in particular to a traditional Chinese medicine preparation prepared from astragalus root and safflower. Background technique: [0002] Astragalus is the dried root of Astragalus membranaceus var.mongholicus Hsiao, a leguminous plant. [0003] Astragalus: Mainly contains astragaloside I, acetyl astragaloside I, isoastragloside I, etc. The pharmacological effects mainly include: [0004] ① Effects on the immune system: It can enhance the body's specific and non-specific immune functions. [0005] ②Effect on body metabolism: It can enhance the physiological metabolism of cells. [0006] ③Effects on the blood system: significantly inhibit platelet aggregation. [0007] ④ Antihypertensive effect, improve microcirculation. [0008] ⑤ anti-inflammatory effect. [0009] For serum nephritis, it can significantly reduce the amount ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K36/481A61K9/00A61P9/00
Inventor 任武贤李亚政冯伟卫银波
Owner YABAO PHARMA GRP CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com